From what i understand the answer is no (99% sure)

From what i understand the answer is no (99% sure).

We own shares of the parent company AMBS and the parent company owns ESS, ELTO and MANF.

So now AMBS parent company is lets say about 7 million worth (market cap).

Now for example, they spinoff ESS, ELTO and MANF with succes and they become their own fully owned subsidiaries led with their own managements.

So AMBS will own 3 companies.

Say ELTO is worth 20 million.
Say MANF is worth 100 million
and lets say ESS is worth 30 million after they IPO.

That means that AMBS should be worth 150 million market cap (let me remind everyone that we were worth 160 million market cap before we acquired the ESS product and were ruined because of the toxics.).

So an 150 million market cap would be around true-er value then we are right now sitting at 7 million market cap.

So that would mean if AMBS management would execute properly on their business plans then you could be looking at a 21 times higher pps then where we are now.

And thats just a normal valuation like other peer companies.

But say we also produce some good data this year (or the next) from any of our products then we could potentially be worth a whole lot more then the 150 million market cap.

Everything falls down to good execution.

I like the risk/reward scenario. There is lots of upside to the pps.

GL